Ie Ming Shih, MD

Photos

1800 Orleans St
Baltimore, MD 21287
Dr. Ie-Ming Shih is the Richard TeLinde Distinguished Professor in the Department of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine. Dr. Shih directs the inter-departmental TeLinde Gynecologic Disease Program and co-directs the Women‘s Malignancy Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medical Institutions. He is the Principal Investigator of the NIH Specialized Program of Research Excellence (SPORE) of Ovarian Cancer focusing on concept-driven clinical trials and early detection of the disease. Dr. Shih's research has been continuously supported by National Institute of Health.Dr. Shih received his M.D. from Taipei Medical University and earned his Ph.D. from the University of Pennsylvania. Dr. Shih went on completing a clinical fellowship in gynecologic pathology and a research fellowship in cancer genetics at Johns Hopkins before joining the faculty in 2001.The scientific contributions from his team include 1) molecular characterization of different types of ovarian cancer, 2) elucidation of the origin and evolution trajectory of ovarian precancerous lesions, 3) the discovery of cancer- promoting genes that are amenable for targeting, 4) the etiology of endometriosis and 5) the pathogenesis of gestational trophoblastic neoplasm. Dr. Shih has published more than 360 original publications and book chapters related to basic and translational cancer research, especially in the study of gynecological malignancies. He has received the 2017 Most Influential Research Paper Award in gynecologic diseases by the Columbia Hospital Foundation, and several research awards from the Tina’s Wish Bozeman Foundation, Gray Foundation, and the Endometriosis Foundation of America to support and recognize his research works.He sits in several advisory/editorial boards such as the World Health Organization (WHO) Nomenclature Committee for Gynecologic Neoplasms and the NCI Ovarian Task Force of Gynecologic Cancer Steering Committee. Besides his clinical, research and teaching obligations, Dr. Shih is a passionate photographer.
Request an Appointment
Owner verified
See a problem?

You might also like

Garry R. Cutting, MD
Internal medicine practitioners

Garry R. Cutting, MD

Dr. Garry R. Cutting is a Professor of Pediatrics and Medicine in the McKusick-Nathans Institute of Genetic Medicine of the Johns Hopkins University School of Medicine. He is the Aetna/U.S. Healthcare Professor of Medical Genetics at Johns Hopkins. Dr. Cutting received his undergraduate degree in biology and medical degree from the University of Connecticut. He completed residency training in pediatrics and a fellowship in medical genetics at the Johns Hopkins University School of Medicine. Dr. Cutting is the Medical Director of the DNA Diagnostic Laboratory of Johns Hopkins Genomics. He directed the Medical Genetics Residency Program at Hopkins from 1995 to 2004.Dr. Cutting is the recipient of the Paul di Sant’Agnese Distinguished Scientific Achievement Award from the Cystic Fibrosis Foundation and a MERIT award from the National Institutes of Health. He has published more than 160 peer-reviewed articles. Dr. Cutting was elected to the Society of Pediatric Research (1992), the American Society of Clinical Investigation (1995) and the Association of American Physicians (2017). Dr. Cutting’s primary interests lie in the interpretation of DNA variation and their effect upon human phenotypes. Dr. Cutting’s lab focuses on the effect of common and rare variants in the CFTR gene that cause the single gene disorder cystic fibrosis (CF). His lab operates the CFTR2 database, a resource composed of clinical and genetic data on almost 90,000 individuals with CF world-wide. His laboratory also studies the effect of clinically approved and novel modulators upon CFTR protein bearing disease-causing variants. Dr. Cutting’s laboratory is also leader in the identification and characterization of genetic modifiers of cystic fibrosis. His group is currently collaborating with teams at the University of North Carolina and the University of Washington, Seattle to identify common and rare modifier variants of disease severity by whole genome sequencing of 5200 individuals with CF. Dr. Cutting participates in the clinical translation of variant interpretation as the Medical Director of the DNA Diagnostic Laboratory at Johns Hopkins. Finally, as Editor of the journal Human Mutation Dr. Cutting oversees the review and publication of manuscripts reporting the mechanism, distribution and phenotype consequences of variation in our genomes.
United StatesMarylandBaltimoreIe Ming Shih, MD

Yext

Partial Data by Foursquare.